CVSC have Cardiovascular Sciences Inc. exposed to more stock investors 800.940.6559.

Cardiovascular Sciences Inc. Details:

Cardiovascular Sciences Inc., a technology company, focuses on the development of medical products. Its products include Anti Adhesion Technology products to prevent post surgical scarring; Pyruvate Therapy, a patented method for treating patients suffering from cardiac trauma, such as ischemic reperfusion injury, heart failure, and bypass surgery; Thromboresistant Coating that prevents blood clot formation on medical devices; a biocompatible Human Vascular Tissue Equivalent for artery replacement during heart surgeries; and patented Aortic Catheters. The company was formerly known as Beverly Hills Weight Loss and Wellness, Inc. and changed its name to Cardiovascular Sciences, Inc. in May 20...
May 17, 2008 1:07 AM ET
CONSUMER DISCRETIONARY SECTOR
 | 
SPECIALTY RETAIL INDUSTRY

Cardiovascular Sciences Inc.

(CVSC:OTC)

CVSC On Other Exchanges
Market Cap
45.5K
Total Revenue
27.0K
EBITDA
--
DILUTED EPS TTM
--
P/E
--
P/S
--
Return On Asset
-71.74
Return On Equity
-289.92
K = Thousands  M = Millions  B = Billions | Data values shown in US Dollar

CVSC Details

Detailed Description...
www.cvsciences.com
4 Employees
  Latest 10-K
  Latest 10-Q
More SEC Filings...

Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

Key developments

Cardiovascular Sciences Inc. Announces Operating Agreement with Medical Technologies Enterprises

Cardiovascular Sciences Inc. announced that the company has reached an operating agreement with Med. Tech. Enterprises Inc. Under this agreement, Cardiovascular Sciences Inc. will immediately assume all daily operations of Med. Tech. Enterprises Inc. Under this agreement, earnings will accrue to the benefit of Cardiovascular Sciences Inc.

Cardiovascular Sciences Inc. Pursues Agreement with Garden State Nutritionals

Cardiovascular Sciences Inc. and Medical Technologies Home Enterprises Inc. announced plans to pursue an agreement with Garden State Nutritionals Inc. The company will negotiate for the manufacture, testing and packaging of a revised line of health promotion supplements with a tie-in to some of the company´s other interests. Arrangements have been made for representatives of Cardiovascular Sciences Inc. to travel to the corporate and manufacturing facilities of Garden State Nutritionals in New Jersey.

Cardiovascular Sciences Inc. Enters into Agreement with Medical Technologies Enterprises, Inc

Cardiovascular Sciences Inc. announce that it has reached a partnership agreement with Medical Technologies Enterprises Inc. of Palm Harbor, FL. Cardiovascular Sciences Inc. is researching and developing its proprietary technology designed to address a need for a better and more effective product to prevent post-surgical adhesions and its complications. Both companies are excited about the possibilities this represents and the likely beneficial impact it will have, not just on the near term financials, but also in the longer term as it allows for an equity-sparing stepping up the pace of development of Cardiovascular Sciences Inc.´s anti-adhesion technology and allows Medical Technologies Enterprises Inc.´s access to and early entry into markets with needs addressed by this technology and other related technologies.

CVSC, chart, Cardiovascular Sciences Inc.

Stock Quotes

Competitors

Company Last Change
No competitor information is available for CVSC.
View Industry Companies
Market data is delayed at least 20 minutes.

Industry Analysis

Valuation CVSC Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

CVSC

View More Transactions...

Speak with other Cardiovascular Sciences Inc. shareholders.


See popular stocks on our site like CVSC